Lack of prognostic significance of neuroendocrine differentiation and stem cell antigen co-expression in resected early-stage non-small cell lung cancer

Anticancer Research

Volumn 33, Issue 3, 2013, Pages 981-990

  Gottschling, Sandra ^a   Jensen, Katrin ^a   Herth, Felix J F ^b   Thomas, Michael ^a   Schnabel, Philipp A ^b   Herpel, Esther ^b  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

ABCG2 antigens; CD117; CD133; Neuroendocrine differentation; Non small cell lung cancer; Stem cell antigens

Indexed keywords

ANTIGEN; BREAST CANCER RESISTANCE PROTEIN; CD133 ANTIGEN; STEM CELL ANTIGEN; STEM CELL FACTOR RECEPTOR; UNCLASSIFIED DRUG;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; CANCER PROGNOSIS; CANCER STAGING; CARCINOID; CELL DIFFERENTIATION; FEMALE; HISTOLOGY; HUMAN; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; NEUROENDOCRINE TUMOR; NEUROSECRETORY CELL; PRIORITY JOURNAL;

AGED; ANTIGENS, CD; ATP-BINDING CASSETTE TRANSPORTERS; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; GLYCOPROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM PROTEINS; NEOPLASM STAGING; PEPTIDES; PROGNOSIS; PROTO-ONCOGENE PROTEINS C-KIT;

EID: 84875889683     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Jemal A, Siegel R, Xu J and Ward E: Cancer statistics, 2010. CA Cancer J Clin 60: 277-300, 2010.
2. Gustafsson BI, Kidd M, Chan A, Malfertheiner MV and Modlin IM: Bronchopulmonary neuroendocrine tumors. Cancer 113: 5-21, 2008.
3. Schleusener JT, Tazelaar HD, Jung S-H, Cha SS, Cera PJ, Myers JL, Creagan ET, Goldberg RM and Marschke RF: Neuroendocrine differentiation is an independent prognostic factor in chemotherapy-treated non-small cell lung cancer. Cancer 77: 1284-1291, 1996.
4. Travis WD, Brambilla E, Muller-Hermelink HK and Harris CC: World Health Organization Classification of Tumours. Pathology and Genetics. Tumours of the Lung, Pleura, Thymus and Heart. Lyon: IARC press, 2004.
5. LaPoint RJ, Bourne PA, Wang HL and Xu H: Coexpression of ckit and bcl-2 in small cell carcinoma and large cell neuroendocrine carcinoma of the lung. Appl Immunohistochem Mol Morphol 15: 401-406, 2007.
6. Granberg D, Wilander E and Oberg K: Expression of tyrosine kinase receptors in lung carcinoids. Tumour Biol 27: 153-157, 2006.
7. Butnor KJ, Burchette JL, Sporn TA, Hammar SP and Roggli VL: The spectrum of Kit (CD117) immunoreactivity in lung and pleural tumors: a study of 96 cases using a single-source antibody with a review of the literature. Arch Pathol Lab Med 128: 538-543, 2004.
8. Araki K, Ishii G, Yokose T, Nagai K, Funai K, Kodama K, Nishiwaki Y and Ochiai A: Frequent overexpression of the c-kit protein in large cell neuroendocrine carcinoma of the lung. Lung Cancer 40: 173-180, 2003.
9. Nomura M, Fukuda T, Fujii K, Kawamura T, Tojo H, Kihara M, Bando Y, Gazdar AF, Tsuboi M, Oshiro H, Nagao T, Ohira T, Ikeda N, Gotoh N, Kato H, Marko-Varga G and Nishimura T: Preferential expression of potential markers for cancer stem cells in large cell neuroendocrine carcinoma of the lung. An FFPE proteomic study. J Clin Bioinforma 1: 23, 2011.
10. Ryuge S, Sato Y, Jiang SX, Wang G, Matsumoto T, Katono K, Inoue H, Iyoda A, Satoh Y, Yoshimura H and Masuda N: Prognostic impact of nestin expression in resected large cell neuroendocrine carcinoma of the lung. Lung Cancer 77: 415-420, 2012.
11. Zhao P, Hou N, Shao Y and Li XH: Clinicopathological significance of expression of c-KIT protein in neuroendocrine lung carcinoma. Zhonghua Yi Xue Za Zhi 85: 1526-1529, 2005.
12. Fujiwara T, Hiramatsu M, Isagawa T, Ninomiya H, Inamura K, Ishikawa Ss, Ushijima M, Matsuura M, Jones MH, Shimane M, Nomura H, Ishikawa Y and Aburatani H: ASCL-coexpression profiling but not single gene expression profiling defines lung adenocarcinomas of neuroendocrine nature with poor prognosis. Lung Cancer 75: 119-125, 2012.
13. Jiang T, Collins BJ, Jin N, Watkins DN, Brock MV, Matsui W, Nelkin BD and Ball DW: Achaete-scute complex homologue 1 regulates tumor-initiating capacity in human small cell lung cancer. Cancer Res 69: 845-854, 2009.
14. Bertolini G, Roz L, Perego P, Tortoreto M, Fontanella E, Gatti L, Pratesi G, Fabbri A, Andriani F, Tinelli S, Roz E, Caserini R, Lo Vullo S, Camerini T, Mariani L, Delia D, Calabro E, Pastorino U and Sozzi G. Highly tumorigenic lung cancer CD133+ cells display stem-like features and are spared by cisplatin treatment. Proc Natl Acad Sci USA 106: 16281-16286, 2009.
15. Salnikov AV, Gladkich J, Moldenhauer G, Volm M, Mattern J and Herr I: CD133 is indicative of a resistance phenotype but does not represent a prognostic marker for survival of non-small cell lung cancer patients. Int J Cancer 126: 950-958, 2010.
16. Eramo A, Lotti F, Sette G, Pilozzi E, Biffoni M, Di Virgilio A, Conticello C, Ruco L, Peschle C and De Maria R: Identification and expansion of the tumorigenic lung cancer stem cell population. Cell Death Diff 15: 504-514, 2008.
17. Li F, Zeng H and Ying K: The combination of stem cell markers CD133 and ABCG2 predicts relapse in stage I non-small cell lung carcinomas. Med Oncol 28: 1458-1462, 2011.
18. Woo T, Okudela K, Mitsui H, Yazawa T, Ogawa N, Tajiri M, Yamamoto T, Rino Y, Kitamura H and Masuda M: Prognostic value of CD133 expression in stage I lung adenocarcinomas. Int J Clin Exp Pathol 4: 32-42, 2011.
19. Herpel E, Jensen K, Muley T, Warth A, Schnabel PA, Meister M, Herth FJF, Dienmann H, Thomas M and Gottschling: The cancer stem cell antigens CD133, BCRP1/ABCG2 and CD117/c-KIT are not associated with prognosis in resected early-stage non-small cell lung cancer. Anticancer Res 31: 4491-500, 2011.
20. Ota S, Ishii G, Goto K, Kubota K, Kim YH, Kojika M, Murata Y, Yamazaki M, Nishiwaki Y, Eguchi K and Ochiai A: Immunohistochemical expression of BCRP1 and ERCC1 in biopsy specimen predicts survival in advanced non-small cell lung cancer treated with cisplatin-based chemotherapy. Lung Cancer 64: 98-104, 2009.
21. Goeckenjan G, Sitter H, Thomas M, Branscheid D, Flentje M, Griesinger F, Niederle N, Stuschke M, Blum T, Deppermann KM, Ficker JH, Freitag L, Lubbe AS, Reinhold T, Spath-Schwalbe E, Ukena D, Wickert M, Wolf M, Andreas S, Auberger T, Baum RP, Baysal B, Beuth J, Bickeboller H, Bocking A, Bohle RM, Bruske I, Burghuber O, Dickgreber N, Diederich S, Dienemann H, Eberhardt W, Eggeling S, Fink T, Fischer B, Franke M, Friedel G, Gauler T, Gutz S, Hautmann H, Hellmann A, Hellwig D, Herth F, Heussel CP, Hilbe W, Hoffmeyer F, Horneber M, Huber RM, Hubner J, Kauczor HU, Kirchbacher K, Kirsten D, Kraus T, Lang SM, Martens U, Mohn-Staudner A, Muller KM, Muller-Nordhorn J, Nowak D, Ochmann U, Passlick B, Petersen I, Pirker R, Pokrajac B, Reck M, Riha S, Rube C, Schmittel A, Schonfeld N, Schutte W, Serke M, Stamatis G, Steingraber M, Steins M, Stoelben E, Swoboda L, Teschler H, Tessen HW, Weber M, Werner A, Wichmann HE, Irlinger Wimmer E, Witt C and Worth H: Prevention, diagnosis, therapy, and follow-up of lung cancer. Pneumologie 64(Suppl): S23-S155, 2010.
22. Detterbeck FC, Boffa DJ and Tanoue LT: The new lung cancer staging system. Chest 136: 260-271, 2009.
23. Warth A, Muley T, Meister M, Stenzinger A, Thomas M, Schirmacher P, Schnabel PA, Budczies J, Hoffmann H and Weichert W: The novel histologic International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society classification system of lung adenocarcinoma is a stage-independent predictor of survival. J Clin Oncol 30: 1438-1446, 2012.
24. Schnabel PA, Petersen I and Junker K. Current issues in pulmonary pathology: Report of the working group on pulmonary pathology of the German Society of Pathology. Pathologe 33(Suppl 2): 351-354, 2012 (in German).
25. Sundaresan V, Reeve JG, Stenning S, Stewart S and Bleehen NM: Neuroendocrine differentiation and clinical behaviour in non-small cell lung tumours. Br J Cancer 64: 333-338, 1991.
26. Graziano SL, Tatum AH, Newman NB, Oler A, Kohmann LJ, Veit LJ, Gamble GP, Coleman MJ, Barmada S and O'Lear S: The prognostic significance of neuroendocrine markers and carcinoembryonic antigen in patients with resected stage I and II non-small cell lung cancer. Cancer Res 54: 2908-2913, 1994.
27. Linnoila RI, Piantadosi S and Ruckdeschel JC: Impact of neuroendocrine differentiation in non-small cell lung cancer: The LCSG experience. Chest 106: 367S-371S, 1994.
28. Kibbelaar RE, Moolenaar KEC, Michalides RJ, Van Bodegom PC, Vanderschueren RG, Wagenaar SS, Dingemans KP, Bitter- Suermann D, Dalesio O and Van Zandwijk N: Neural cell adhesion molecule expression, neuroendocrine differentiation and prognosis in lung carcinoma. Eur J Cancer 27: 431-435, 1991.
29. Berendsen HH, de Leij L, Poppema S, Postmus PE, Boes A, Sluiter HJ and The H: Clinical characterization of non-small cell lung cancer tumors showing neuroendocrine differentiation features. J Clin Oncol 7: 1614-1620, 1989.
30. Howe MC, Chapman A, Kerr K, Dougal M, Anderson H and Hasleton PS: Neuroendocrine differentiation in non-small cell lung cancer and its relation to prognosis and therapy. Histopathology 46: 105-201, 2005.
31. Harada M, Yokose T, Yoshida J, Nishiwaki Y and Nagai K: Immunohistochemical neuroendocrinee differentiation is an independent prognostic factor in surgically resected large cell carcinoma of the lung. Lung Cancer 38: 177-184, 2002.
32. Slodkowska J, Zych J, Szturmowicz M, Demkow U, Rowinska- Zakrzewska E and Roszkowski-Sliz K: Neuroendocrine phenotype of non-small cell lung carcinoma: Immunohistological evaluation and biochemical study. Int J Biol Markers 20: 217-226, 2005.
33. Song H, Yao E, Lin C, Gacayan R, Chen MH and Chuang PT: Functional characterization of pulmonary neuroendocrine cells in lung development, injury, and tumorigenesis. Proc Natl Acad Sci USA 109: 17531-17536, 2012.
34. Moreira AL, Gonen M, Rekhtman N and Downey RJ: Progenitor stem cell marker expression by pulmonary carcinomas. Mod Pathol 23: 889-895, 2010.
35. Yaren A, Oztop I, Kargi A, Ulukus C, Onen A, Sanli A, Binicier O, Yilmaz U and Alakavuklar M: BAX, BCL-2 and c-KIT expression in non-small cell lung cancer and their effects on prognosis. Int J Clin Pract 60: 675-682, 2006.